Literature DB >> 3126817

Identification of prostaglandin D2 as the major eicosanoid from liver endothelial and Kupffer cells.

J Kuiper1, F J Zijlstra, J A Kamps, T J van Berkel.   

Abstract

The capacity of freshly isolated endothelial, Kupffer and parenchymal rat liver cells to produce eicosanoids from [1-14C]arachidonic acid was investigated in order to determine the relative importance of these cells to total liver eicosanoid production. Based upon the total formation of [1-14C]arachidonate metabolites in the liver, it can be calculated that Kupffer and endothelial cells are responsible for 65 and 23%, respectively, of the total amount of eicosanoids produced by the liver. Consequently, parenchymal liver cells, representing 92.5% of the total liver mass, contribute only 12% to the total liver production of eicosanoids. The main product of Kupffer cells was prostaglandin D2 (PGD2), representing 55% of the total amount of eicosanoids produced. Liver endothelial cells produced about 4-times less eicosanoids (per mg cell protein) than Kupffer cells, and PGD2 was also the main product of these cells (44%). The production of eicosanoids by parenchymal cells was lower by a factor of 180 (per mg cell protein) than that in Kupffer cells. Besides the ability to form eicosanoids from added 14C-labeled arachidonic acid, Kupffer and endothelial liver cells were also able to produce significant amounts of PGD2 (the main liver prostaglandin) from endogenous arachidonic acid, as determined by a radioimmunoassay. It is concluded that inside the liver, Kupffer cells together with endothelial cells are of major importance in the production of eicosanoids, while the parenchymal cells may be considered metabolic target cells for these products, as indicated by the finding that the major liver prostaglandin, PGD2, could stimulate the glucose output in isolated parenchymal cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3126817     DOI: 10.1016/0005-2760(88)90025-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  21 in total

1.  The role of prostaglandins in endotoxin stimulated glycogenolysis in the liver.

Authors:  J Kuiper; E Casteleyn; T J van Berkel
Journal:  Agents Actions       Date:  1989-01

2.  Cellular communication inside the liver. Binding, conversion and metabolic effect of prostaglandin D2 on parenchymal liver cells.

Authors:  J Kuiper; F J Zijlstra; J A Kamps; T J Van Berkel
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

3.  Action of endothelins on hepatic stellate cells.

Authors:  N Kawada; T Kuroki; K Kobayashi; M Inoue; K Kaneda; K Decker
Journal:  J Gastroenterol       Date:  1995-12       Impact factor: 7.527

4.  Interleukin-6, but not tumour necrosis factor-alpha, increases lipogenesis in rat hepatocyte primary cultures.

Authors:  E P Brass; W H Vetter
Journal:  Biochem J       Date:  1994-07-01       Impact factor: 3.857

5.  Lipid peroxidation is a nonparenchymal cell event with reperfusion after prolonged liver ischemia.

Authors:  T R Walsh; P N Rao; L Makowka; T E Starzl
Journal:  J Surg Res       Date:  1990-07       Impact factor: 2.192

6.  Immunohistochemical demonstration of prostaglandins in various tissues of the rat.

Authors:  M Miyauchi; T Takata; I Ogawa; H Ito; J Kobayashi; H Nikai; N Ijuhin
Journal:  Histochem Cell Biol       Date:  1996-01       Impact factor: 4.304

7.  Arachidonate metabolism in D-galactosamine or carbon tetrachloride-induced acute and chronic liver injuries in rats.

Authors:  P Liu; N Kawada; Y Mizoguchi; S Morisawa
Journal:  Gastroenterol Jpn       Date:  1992-10

8.  Prostaglandin E1 (PGE1) attenuates vasoconstriction induced by PGE2, PGD2 and phorbol myristate acetate in the perfused rat liver.

Authors:  H Inaba; M Araki; T Numai; T Mizuguchi
Journal:  J Anesth       Date:  1993-01       Impact factor: 2.078

Review 9.  Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.

Authors:  Edwin S Van Amersfoort; Theo J C Van Berkel; Johan Kuiper
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

10.  Non-insulin-like action of sodium orthovanadate in the isolated perfused liver of fed, non-diabetic rats.

Authors:  M Roden; K Liener; C Fürnsinn; M Prskavec; P Nowotny; I Steffan; H Vierhapper; W Waldhäusl
Journal:  Diabetologia       Date:  1993-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.